BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10230406)

  • 1. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha.
    Tan P; Fuchs SY; Chen A; Wu K; Gomez C; Ronai Z; Pan ZQ
    Mol Cell; 1999 Apr; 3(4):527-33. PubMed ID: 10230406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.
    Wu K; Fuchs SY; Chen A; Tan P; Gomez C; Ronai Z; Pan ZQ
    Mol Cell Biol; 2000 Feb; 20(4):1382-93. PubMed ID: 10648623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
    Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
    Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.
    Winston JT; Strack P; Beer-Romero P; Chu CY; Elledge SJ; Harper JW
    Genes Dev; 1999 Feb; 13(3):270-83. PubMed ID: 9990852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of substrate and Skp1 by the Homologue of Slimb (HOS) ubiquitin ligase receptor D role of the F-box.
    Herter JR; Fuchs SY
    Med Sci Monit; 2002 Aug; 8(8):BR283-8. PubMed ID: 12165731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization.
    Wu K; Chen A; Pan ZQ
    J Biol Chem; 2000 Oct; 275(41):32317-24. PubMed ID: 10921923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB.
    Bhatia N; Herter JR; Slaga TJ; Fuchs SY; Spiegelman VS
    Oncogene; 2002 Feb; 21(10):1501-9. PubMed ID: 11896578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex.
    Dias DC; Dolios G; Wang R; Pan ZQ
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16601-6. PubMed ID: 12481031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
    Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
    Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases.
    Ohta T; Xiong Y
    Cancer Res; 2001 Feb; 61(4):1347-53. PubMed ID: 11245432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2.
    Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Suzuki T; Ichiyama A; Ikenoue T; Omata M; Furuichi K; Tanaka K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):127-32. PubMed ID: 10066435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway.
    Tanaka K; Kawakami T; Tateishi K; Yashiroda H; Chiba T
    Biochimie; 2001; 83(3-4):351-6. PubMed ID: 11295496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.
    Ohta T; Michel JJ; Schottelius AJ; Xiong Y
    Mol Cell; 1999 Apr; 3(4):535-41. PubMed ID: 10230407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1.
    Hatakeyama S; Kitagawa M; Nakayama K; Shirane M; Matsumoto M; Hattori K; Higashi H; Nakano H; Okumura K; OnoƩ K; Good RA; Nakayama K
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3859-63. PubMed ID: 10097128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel 300-kDa factor termed IkappaB alphaE3-F1 that is required for ubiquitinylation of IkappaB alpha.
    Suzuki H; Kobayashi M; Takeuchi M; Furuichi K; Chiba T; Tanaka K
    FEBS Lett; 1999 Sep; 458(3):343-8. PubMed ID: 10570937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha.
    Read MA; Brownell JE; Gladysheva TB; Hottelet M; Parent LA; Coggins MB; Pierce JW; Podust VN; Luo RS; Chau V; Palombella VJ
    Mol Cell Biol; 2000 Apr; 20(7):2326-33. PubMed ID: 10713156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3 ligase and regulates its stability.
    Morimoto M; Nishida T; Nagayama Y; Yasuda H
    Biochem Biophys Res Commun; 2003 Feb; 301(2):392-8. PubMed ID: 12565873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIP120A associates with cullins and modulates ubiquitin ligase activity.
    Min KW; Hwang JW; Lee JS; Park Y; Tamura TA; Yoon JB
    J Biol Chem; 2003 May; 278(18):15905-10. PubMed ID: 12609982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.
    Fuchs SY; Chen A; Xiong Y; Pan ZQ; Ronai Z
    Oncogene; 1999 Mar; 18(12):2039-46. PubMed ID: 10321728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.